Home HIV	FAQ My Amedeo About	Flying Publisher
	Amedeo Prize 2008 The 21 Finalists

Cytomegalovirus Infection

Free Subscription Articles published in Transplantation Retrieve available abstracts of 89 articles: HTML format

Single Articles

April 2008
1. ZHANG Z , Kim SJ, Varghese T, Thomas G, et al
   TNF Receptor Independent Activation of the Cytomegalovirus Major Immediate Early Enhancer in Response to Transplantation.
   Transplantation. 2008;85:1039-1045.
   PubMed     Related articles    Abstract available
   
   
   December 2007
2. TANABE K
   Japanese experience of ABO-incompatible living kidney transplantation.
   Transplantation. 2007;84.
   PubMed     Related articles    Abstract available
   
   
   
3. HILL JA , Hummel M, Starling RC, Kobashigawa JA, et al
   A Lower Incidence of Cytomegalovirus Infection in De Novo Heart Transplant Recipients Randomized to Everolimus.
   Transplantation. 2007;84:1436-1442.
   PubMed     Related articles    Abstract available
   
   
   November 2007
4. ZANDBERG M , van Son WJ, Harmsen MC, Bakker WW, et al
   Infection of human endothelium in vitro by cytomegalovirus causes enhanced expression of purinergic receptors: a potential virus escape mechanism?
   Transplantation. 2007;84:1343-7.
   PubMed     Related articles    Abstract available
   
   
   
5. VALDERHAUG TG , Hjelmesaeth J, Rollag H, Leivestad T, et al
   Reduced Incidence of New-Onset Posttransplantation Diabetes Mellitus During the Last Decade.
   Transplantation. 2007;84:1125-1130.
   PubMed     Related articles    Abstract available
   
   
   
6. SAKURAI R , Yamasaki M, Nakamura M, Hirohata A, et al
   Determinants of lumen loss between years 1 and 2 after cardiac transplantation.
   Transplantation. 2007;84:1097-102.
   PubMed     Related articles    Abstract available
   
   
   
7. KIM HJ , Choi Y, Min WS, Kim TG, et al
   The activating killer cell immunoglobulin-like receptors as important determinants of acute graft-versus host disease in hematopoietic stem cell transplantation for acute myelogenous leukemia.
   Transplantation. 2007;84:1082-91.
   PubMed     Related articles    Abstract available
   
   
   September 2007
8. NEBBIA G , Mattes FM, Sabin CA, Samonakis D, et al
   Differential Effects of Prednisolone and Azathioprine on the Development of Human Cytomegalovirus Replication Post Liver Transplantation.
   Transplantation. 2007;84:605-610.
   PubMed     Related articles    Abstract available
   
   
   July 2007
9. ZEDTWITZ-LIEBENSTEIN K , Jaksch P, Wulkersdorfer B, Friehs H, et al
   Usefulness of Interleukin-10 Detection in Lung Transplant Patients With Human Cytomegalovirus Infection With Respect to Virus Persistence.
   Transplantation. 2007;84:268-271.
   PubMed     Related articles    Abstract available
   
   
   
10. PESCOVITZ MD
    Is low-dose valganciclovir the same as appropriate-dose valganciclovir?
    Transplantation. 2007;84:126.
    PubMed     Related articles   
    
    
    June 2007
11. CERVERA C , Lozano F, Saval N, Gimferrer I, et al
    The Influence of Innate Immunity Gene Receptors Polymorphisms in Renal Transplant Infections.
    Transplantation. 2007;83:1493-1500.
    PubMed     Related articles    Abstract available
    
    
    May 2007
12. HUMAR A , Kumar D, Gray M, Moussa G, et al
    A Prospective Assessment of Cytomegalovirus Immune Evasion Gene Transcription Profiles in Transplant Patients With Cytomegalovirus Infection.
    Transplantation. 2007;83:1200-1206.
    PubMed     Related articles    Abstract available
    
    
    April 2007
13. WALKER JK , Scholz LM, Scheetz MH, Gallon LG, et al
    Leukopenia complicates cytomegalovirus prevention after renal transplantation with alemtuzumab induction.
    Transplantation. 2007;83:874-82.
    PubMed     Related articles    Abstract available
    
    
    
14. FLECHNER SM , Goldfarb D, Solez K, Modlin CS, et al
    Kidney transplantation with sirolimus and mycophenolate mofetil-based immunosuppression: 5-year results of a randomized prospective trial compared to calcineurin inhibitor drugs.
    Transplantation. 2007;83:883-92.
    PubMed     Related articles    Abstract available
    
    
    March 2007
15. FEARON WF , Potena L, Hirohata A, Sakurai R, et al
    Changes in coronary arterial dimensions early after cardiac transplantation.
    Transplantation. 2007;83:700-5.
    PubMed     Related articles    Abstract available
    
    
    
16. CHUNG H , Kim KH, Kim JG, Lee SY, et al
    Retinal complications in patients with solid organ or bone marrow transplantations.
    Transplantation. 2007;83:694-9.
    PubMed     Related articles    Abstract available
    
    
    February 2007
17. WENDERFER SE , Swinford RD, Mauiyyedi S, Witte DP, et al
    Cytomegalovirus and Recurrent Idiopathic Membranoproliferative Glomerulonephritis Type 1: Cause or Consequence?
    Transplantation. 2007;83:523-524.
    PubMed     Related articles   
    
    
    
18. MANUEL O , Pascual M, Trendelenburg M, Meylan PR, et al
    Association Between Mannose-Binding Lectin Deficiency and Cytomegalovirus Infection After Kidney Transplantation.
    Transplantation. 2007;83:359-362.
    PubMed     Related articles    Abstract available
    
    
    
19. WENG FL , Patel AM, Wanchoo R, Brahmbhatt Y, et al
    Oral Ganciclovir Versus Low-Dose Valganciclovir for Prevention of Cytomegalovirus Disease in Recipients of Kidney and Pancreas Transplants.
    Transplantation. 2007;83:290-296.
    PubMed     Related articles    Abstract available
    
    
    January 2007
20. MANUEL O , Meylan PR, Rotman S, Fontana M, et al
    Oral Valganciclovir for Cytomegalovirus Colitis After Liver Transplantation.
    Transplantation. 2007;83:239-240.
    PubMed     Related articles   
    
    
    
21. XHAARD A , Robin M, Scieux C, de Latour RP, et al
    Increased Incidence of Cytomegalovirus Retinitis After Allogeneic Hematopoietic Stem Cell Transplantation.
    Transplantation. 2007;83:80-83.
    PubMed     Related articles    Abstract available
    
    
    December 2006
22. COOKE ME , Potena L, Luikart H, Valantine HA, et al
    Peripheral blood leukocyte counts in cytomegalovirus infected heart transplant patients: impact of acute disease versus subclinical infection.
    Transplantation. 2006;82:1419-24.
    PubMed     Related articles    Abstract available
    
    
    November 2006
23. PUELLMANN K , Beham A, Kienle K, Vogel M, et al
    Inhibition of apoptosis reduces immunogeneic potential of adenoviral-treated syngeneic liver grafts.
    Transplantation. 2006;82:1377-82.
    PubMed     Related articles    Abstract available
    
    
    October 2006
24. UZUNEL M , Remberger M, Sairafi D, Hassan Z, et al
    Unrelated versus related allogeneic stem cell transplantation after reduced intensity conditioning.
    Transplantation. 2006;82:913-9.
    PubMed     Related articles    Abstract available
    
    
    August 2006
25. POTENA L , Holweg CT, Chin C, Luikart H, et al
    Acute Rejection and Cardiac Allograft Vascular Disease Is Reduced by Suppression of Subclinical Cytomegalovirus Infection.
    Transplantation. 2006;82:398-405.
    PubMed     Related articles    Abstract available
    
    
    July 2006
26. HUMAR A
    Reactivation of viruses in solid organ transplant patients receiving cytomegalovirus prophylaxis.
    Transplantation. 2006;82 Suppl 2:S9-S14.
    PubMed     Related articles    Abstract available
    
    
    
27. PESCOVITZ MD
    Benefits of cytomegalovirus prophylaxis in solid organ transplantation.
    Transplantation. 2006;82 Suppl 2:S4-8.
    PubMed     Related articles    Abstract available
    
    
    
28. HARTMANN A , Sagedal S, Hjelmesaeth J
    The Natural Course of Cytomegalovirus Infection and Disease in Renal Transplant Recipients.
    Transplantation. 2006;82 Suppl 2:S15-S17.
    PubMed     Related articles    Abstract available
    
    
    
29. MONACO AP , Morris PJ
    Editorial comment: the other consequences of CMV infection.
    Transplantation. 2006;82 Suppl 2:S1-2.
    PubMed     Related articles   
    
    
    
30. DIAZ-PEDROCHE C , Lumbreras C, San Juan R, Folgueira D, et al
    Valganciclovir preemptive therapy for the prevention of cytomegalovirus disease in high-risk seropositive solid-organ transplant recipients.
    Transplantation. 2006;82:30-5.
    PubMed     Related articles    Abstract available
    
    
    
31. SINGH N
    Optimization of outcomes related to cytomegalovirus in organ transplant recipients.
    Transplantation. 2006;82:15-6.
    PubMed     Related articles   
    
    
    
32. 
    CMV enhances expression of wound healing and innate/adaptive immunity genes during the development of transplant vascular sclerosis in rat cardiac allografts.
    Transplantation. 2006;82.
    PubMed     Related articles   
    
    
    
33. 
    A pharmacoeconomic analysis of prophylactic vs preemptive valganciclovir for the management of CMV in renal transplant recipients.
    Transplantation. 2006;82.
    PubMed     Related articles   
    
    
    
34. 
    The influence of anti-cd20 antibody (rituximab) induction therapy on cytomegalovirus (CMV) infection in living related renal transplantation.
    Transplantation. 2006;82.
    PubMed     Related articles   
    
    
    
35. 
    IMMUNOREGULATION OF THYMOSINa1 TREATMENT OF CYTOMEGALOVIRUS INFECTION ACCOMPANIED WITH ARDS AFTER RENAL TRANSPLANTATION.
    Transplantation. 2006;82.
    PubMed     Related articles   
    
    
    
36. 
    Cytomegalovirus shedding does not influence gene expression in bronchoalveolar lavage cells after lung transplantation.
    Transplantation. 2006;82.
    PubMed     Related articles   
    
    
    
37. 
    Disruption of allograft tolerance by CMV reactivation.
    Transplantation. 2006;82.
    PubMed     Related articles   
    
    
    
38. 
    Clinical characteristics and outcomes of cytomegalovirus (CMV) retinitis in transplant recipients.
    Transplantation. 2006;82.
    PubMed     Related articles   
    
    
    
39. 
    Strong selection of class-ii restricted CMV-specific cytotoxic cd4+ T cells during primary CMV infection.
    Transplantation. 2006;82.
    PubMed     Related articles   
    
    
    
40. 
    Clinical features and outcomes of delayed onset primary cytomegalovirus (CMV) disease in cardiac allograft recipients.
    Transplantation. 2006;82.
    PubMed     Related articles   
    
    
    
41. 
    CMV transmission in type 1 diabetic recipients of islet versus whole pancreas transplants.
    Transplantation. 2006;82.
    PubMed     Related articles   
    
    
    
42. 
    Epidemiology and risks for CMV in pediatric lung transplantation.
    Transplantation. 2006;82.
    PubMed     Related articles   
    
    
    
43. 
    Cytomegalovirus infection in the upper gastrointestinal tract of patients after kidney transplantation: a prospective study.
    Transplantation. 2006;82.
    PubMed     Related articles   
    
    
    
44. 
    Effect of induction therapy with antithymocyte globulins vs. Anti-cd25 upon cytomegalovirus (CMV) reactivation in CMV-seropositive renal-transplant patients.
    Transplantation. 2006;82.
    PubMed     Related articles   
    
    
    
45. 
    Sirolimus as a co-adjuvant therapy in gancyclovir-resistant cytomegalovirus infections in renal transplant recipients.
    Transplantation. 2006;82.
    PubMed     Related articles   
    
    
    
46. 
    No need of CMV prophylaxis in renal transplanted patients treated with induction therapy.
    Transplantation. 2006;82.
    PubMed     Related articles   
    
    
    
47. 
    Sirolimus (srl)-based immunosuppressive regimen reduces the risk of CMV infection in renal allograft recipients.
    Transplantation. 2006;82.
    PubMed     Related articles   
    
    
    
48. 
    Pharmacokinetic and pharmacodynamic assessement of valganciclovir in the prophylaxis and treatment of CMV disease in solid organ transplant patients.
    Transplantation. 2006;82.
    PubMed     Related articles   
    
    
    
49. 
    Decreased incidence of CMV disease in kidney transplant recipients receiving a steroid avoidance immunosuppression regimen.
    Transplantation. 2006;82.
    PubMed     Related articles   
    
    
    
50. 
    IMMUNOMONITORING OF CMV-SPECIFIC alphabetaCD8 AND gammadeltaT LYMPHOCYTES IN RENAL TRANSPLANTED PATIENTS.
    Transplantation. 2006;82.
    PubMed     Related articles   
    
    
    
51. 
    Severe graft rejection, increased immunosuppression and active CMV infection in renal transplantation.
    Transplantation. 2006;82.
    PubMed     Related articles   
    
    
    
52. 
    Degranulation of T cells specific for human cytomegalovirus (CMV) proteins pp65 and ie1 is not disturbed in transplant patients.
    Transplantation. 2006;82.
    PubMed     Related articles   
    
    
    
53. 
    Efficacy and safety of oral valganciclovir treatment of cytomegalovirus infection after a short induction with ganciclovir iv in solid organ transplantation.
    Transplantation. 2006;82.
    PubMed     Related articles   
    
    
    
54. 
    Efficacy of oral valganciclovir in the treatment of cytomegalovirus infection in renal transplant recipients.
    Transplantation. 2006;82.
    PubMed     Related articles   
    
    
    
55. 
    Clinical and virological outcomes of adding leflunomide to ganciclovir or foscarnet for treatment of CMV viremia in transplant recipients.
    Transplantation. 2006;82.
    PubMed     Related articles   
    
    
    
56. 
    Outcomes of cytomegalovirus infection and disease after lung and heart-lung transplantation with a delayed ganciclovir regimen.
    Transplantation. 2006;82.
    PubMed     Related articles   
    
    
    
57. 
    A single center comparasion between two antiviral prophylaxis regimens for the prevention of cytomegalovirus in kidney transplant mis-match patients.
    Transplantation. 2006;82.
    PubMed     Related articles   
    
    
    
58. 
    Protocol treatment of cytomegalovirus (CMV) viremia.
    Transplantation. 2006;82.
    PubMed     Related articles   
    
    
    
59. 
    Incidence and risk factors of cytomegalovirus disease in adult kidney or simultaneous pancreas-kidney transplant recipients who received valganciclovir prophylaxis.
    Transplantation. 2006;82.
    PubMed     Related articles   
    
    
    
60. 
    Treatment of cytomegalovirus infection or disease in solid organ transplant recipients with oral valganciclovir.
    Transplantation. 2006;82.
    PubMed     Related articles   
    
    
    
61. 
    Reduction of late CMV after prophylaxis by a combined prophylaxis/pre-emptive therapy program in high-risk transplant recipients.
    Transplantation. 2006;82.
    PubMed     Related articles   
    
    
    
62. 
    A clinically effective oral CMV prophylaxis regimen in renal and pancreas transplant recipients using gradations of valganciclovir stratified to risk.
    Transplantation. 2006;82.
    PubMed     Related articles   
    
    
    
63. 
    CMV infection in kidney transplant recipients: evolution of approach through three eras.
    Transplantation. 2006;82.
    PubMed     Related articles   
    
    
    
64. 
    Efficacy of valgancyclovir for the treatment of primary CMV infection in renal transplant recipients.
    Transplantation. 2006;82.
    PubMed     Related articles   
    
    
    
65. 
    Efficacy and safety of CMV prophylaxis with valganciclovir 900 mg/day for 100 days versus 450 mg/day for 6 months post-renal transplantation.
    Transplantation. 2006;82.
    PubMed     Related articles   
    
    
    
66. 
    Low-dose valganciclovir for 3 months prevents cytomegalovirus (CMV) disease in renal and pancreas transplant recipients, including recipients at high-risk for CMV disease.
    Transplantation. 2006;82.
    PubMed     Related articles   
    
    
    
67. 
    Preemptive therapy vs valganciclovir prophylaxis for cytomegalovirus prevention in kidney transplant recipients receiving alemtuzumab induction.
    Transplantation. 2006;82.
    PubMed     Related articles   
    
    
    
68. 
    Extended use of valganciclovir is not associated with development of drug resistant cytomegalovirus in kidney and pancreas transplant patients.
    Transplantation. 2006;82.
    PubMed     Related articles   
    
    
    
69. 
    A timecourse study on the relationship between hscrp, CMV and cardiac allograft vasculopathy.
    Transplantation. 2006;82.
    PubMed     Related articles   
    
    
    
70. 
    Does infection (other than CMV) trigger rejection in heart transplant patients?
    Transplantation. 2006;82.
    PubMed     Related articles   
    
    
    
71. 
    Recurrent cytomegalovirus (CMV) disease in heart transplant patients: a common occurrence.
    Transplantation. 2006;82.
    PubMed     Related articles   
    
    
    
72. 
    Characterization of six novel cytomegalovirus (CMV) ul97 mutations found in a valganciclovir (vgcv)/oral ganciclovir (gcv) prophylactic trial using a new bacterial artificial chromosome (bac) method.
    Transplantation. 2006;82.
    PubMed     Related articles   
    
    
    
73. 
    CMV accelerates chronic allograft nephropathy in a rat renal transplant model with associated provocative chemokine profiles.
    Transplantation. 2006;82.
    PubMed     Related articles   
    
    
    
74. 
    Increased frequency of chronic allograft nephropathy in kidney transplant recipients (CMV +) with transient CMV antigenemia.
    Transplantation. 2006;82.
    PubMed     Related articles   
    
    
    
75. 
    CYTOMEGALOVIRUS INDUCES TRANSFORMING GROWTH FACTOR-beta1 PRODUCTION BY RENAL TUBULAR EPITHELIUM IN VITRO.
    Transplantation. 2006;82.
    PubMed     Related articles   
    
    
    
76. 
    The arg753gln polymorphism in human toll-like receptor-2 (tlr2) is associated with cytomegalovirus (CMV) disease in liver transplant recipients.
    Transplantation. 2006;82.
    PubMed     Related articles   
    
    
    
77. 
    A prospective assessment of CMV immune evasion gene expression profiles in transplant patients with CMV infection.
    Transplantation. 2006;82.
    PubMed     Related articles   
    
    
    
78. 
    Changes in natural killer receptors on T cells during primary CMV infection in kidney transplant recipients.
    Transplantation. 2006;82.
    PubMed     Related articles   
    
    
    
79. 
    Cytomegalovirus (CMV)-specific CD4 and CD8 T cell response to CMV infection in renal transplant patients.
    Transplantation. 2006;82.
    PubMed     Related articles   
    
    
    
80. 
    Efficacy of preemptive therapy with valganciclovir for cytomegalovirus (CMV) in CMV-seronegative liver transplant recipients with CMV-seropositive donors (R-/d+).
    Transplantation. 2006;82.
    PubMed     Related articles   
    
    
    
81. 
    The economic impact of ganciclovir and valacyclovir prophylaxis of cytomegalovirus disease in renal transplantation.
    Transplantation. 2006;82.
    PubMed     Related articles   
    
    
    
82. 
    Cytomegalovirus-specific T-cells in seropositive kidney transplant patients with recurrence.
    Transplantation. 2006;82.
    PubMed     Related articles   
    
    
    
83. 
    Duration of CMV prophylaxis associated with CMV disease in d+/r+ pediatric lung transplant recipients.
    Transplantation. 2006;82.
    PubMed     Related articles   
    
    
    June 2006
84. LIMAYE AP , Bakthavatsalam R, Kim HW, Randolph SE, et al
    Impact of Cytomegalovirus in Organ Transplant Recipients in the Era of Antiviral Prophylaxis.
    Transplantation. 2006;81:1645-1652.
    PubMed     Related articles    Abstract available
    
    
    May 2006
85. RUTTMANN E , Geltner C, Bucher B, Ulmer H, et al
    Combined CMV Prophylaxis Improves Outcome and Reduces the Risk for Bronchiolitis Obliterans Syndrome (BOS) after Lung Transplantation.
    Transplantation. 2006;81:1415-1420.
    PubMed     Related articles    Abstract available
    
    
    April 2006
86. DOYLE AM , Warburton KM, Goral S, Blumberg E, et al
    24-Week Oral Ganciclovir Prophylaxis in Kidney Recipients Is Associated with Reduced Symptomatic Cytomegalovirus Disease Compared to a 12-Week Course.
    Transplantation. 2006;81:1106-1111.
    PubMed     Related articles    Abstract available
    
    
    
87. KNIGHT RJ , Kerman RH, Zela S, Podbielski J, et al
    Pancreas transplantation utilizing thymoglobulin, sirolimus, and cyclosporine.
    Transplantation. 2006;81:1101-5.
    PubMed     Related articles    Abstract available
    
    
    March 2006
88. HUMAR A , Hebert D, Davies HD, Humar A, et al
    A randomized trial of ganciclovir versus ganciclovir plus immune globulin for prophylaxis against Epstein-Barr virus related posttransplant lymphoproliferative disorder.
    Transplantation. 2006;81:856-61.
    PubMed     Related articles    Abstract available
    
    
    
89. DORON S , Ruthazer R, Werner BG, Rabson A, et al
    Hypogammaglobulinemia in Liver Transplant Recipients: Incidence, Timing, Risk Factors, and Outcomes.
    Transplantation. 2006;81:697-703.
    PubMed     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Bernd Sebastian Kamps website.    Design: